Načítá se...
Update on clinical gene therapy for hemophilia
In contrast to other diverse therapies for the X-linked bleeding disorder hemophilia that are currently in clinical development, gene therapy holds the promise of a lasting cure with a single drug administration. Near-to-complete correction of hemophilia A (factor VIII deficiency) and hemophilia B (...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6356985/ https://ncbi.nlm.nih.gov/pubmed/30559260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-07-820720 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|